BSECompany Update21 Aug 2026 · 21 Aug 2026, 10:24 pm
Please find the enclosed intimation of the Company in relation to the captioned subject for your reference.
AstraZeneca Pharma India Ltd · 506820
✦ AI SummaryMgmt Change
AstraZeneca Pharma India Ltd has scheduled an interaction with an institutional investor on August 26, 2026, as per the details given. The interaction will be held virtually and dates are subject to change.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
AstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
295b1ed6-0772-425f-b9ec-ca993fd7c05a.pdf
View document text
August 21, 2026
The Manager – Listing
BSE Limited
P J Towers, Dalal Street, Fort,
Mumbai - 400001
National Stock Exchange of India Ltd.
Exchange Plaza,
Bandra-Kurla Complex, Bandra (E),
Mumbai - 400051
Dear Sirs/ Madam,
Sub: Intimation of Schedule of interaction with Analyst/ Investor
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations,
2015, we hereby inform that an interaction with an institutional investor is scheduled to be held as per
the details given hereunder:
Day, Date Type of Interaction with Location
interaction
Wednesday, One-on-one Institutional Investor Virtual
August 26, 2026 Meeting
Dates are subject to change. Changes may happen due to exigencies on part of the Company / Investor.
We request you to take the same on record.
Thanking you,
For AstraZeneca Pharma India Limited
Tanya Sanish
Company Secretary & Compliance Officer